Skip to content

Book value per share at other companies

Gilead Sciences logo
Gilead SciencesGILD
$18.75+23.2%
Immunome logo
ImmunomeIMNM
$5.20+34.5%
Nuvation Bio logo
Nuvation BioNUVB
$0.85-31.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$0.85-22.2%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$4.67+0.1%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.43-22.1%

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.98B+32.4%
Enterprise value$1.83B+33.2%
P/S6.9×-0.1×

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Iovance Biotherapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s book value per share?
Iovance Biotherapeutics, Inc. (IOVA) reported book value per share of $1.72 in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s book value per share changed year-over-year?
Iovance Biotherapeutics, Inc.'s book value per share decreased by 27.5% year-over-year, from $2.38 to $1.72.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s book value per share has grown at a -15.3% compound annual growth rate (CAGR), from $4.47 to $1.95.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.